Rosuvastatin/ezetimibe combo explores new LDL-lowering territory

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1550, 2006-01, pp. : 15-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ezetimibe/simvastatin: the elite LDL-cholesterol lowering entity?

By  

Inpharma, Vol. 1, Iss. 1551, 2006-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

A New Class of Lipid-Lowering Drugs: Ezetimibe

By  

Heart Drug, Vol. 3, Iss. 4, 2004-02 ,pp. : 214-216

Karger

Access to resources Recommend Favorite

Ezetimibe added to rosuvastatin produces further reductions in LDL-cholesterol levels in patients with severe hypercholesterolaemia

By  

Inpharma, Vol. 1, Iss. 1483, 2005-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

New Lipid-lowering Agents Acting on LDL Receptors

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 3, 2005-01 ,pp. : 233-242

Bentham Science Publishers

Access to resources Recommend Favorite

Ezetimibe lowers LDL-cholesterol levels

By  

Inpharma, Vol. 1, Iss. 1291, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite